Thrombophilia screen
- 12 Dec 2023
- 1 Minute to read
- Print
- PDF
Thrombophilia screen
- Updated on 12 Dec 2023
- 1 Minute to read
- Print
- PDF
Article summary
Did you find this summary helpful?
Thank you for your feedback
Routine thrombophilia testing is not necessary before initiating HRT.
WHEN SHOULD A THROMBOPHILIA SCREEN BE PERFORMED?
NICE says:
- Consider testing for antiphospholipid antibodies in people who have had unprovoked DVT or PE if it is planned to stop anticoagulation treatment, but be aware that these tests can be affected by anticoagulants and specialist advice may be needed.
- Consider testing for hereditary thrombophilia in people who have had unprovoked DVT or PE and who have a first‑degree relative who has had DVT or PE if it is planned to stop anticoagulation treatment but be aware that these tests can be affected by anticoagulants and specialist advice may be needed.
- Do not offer thrombophilia testing in people who have had provoked DVT or PE.
- Do not offer testing for hereditary thrombophilia in people who are continuing anticoagulant treatment.
For more information on thrombophilia testing, see:
NOTE:
- A negative thrombophilia screen does not exclude a thrombophilia.
References and Further Information:
- Hamoda H, Panay N, Pedder H et al. The British Menopause Society and Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health. 2020.
- Arachchillage D, Mackillop L, Chandratheva A et al. Thrombophilia testing: A British society for Haematology Guideline. British Journal of Haematology. 2022.
- NICE Guidance. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. Last updated Aug 2023. Section 1.9.
Was this article helpful?